WO2014104989A8 - Pharmaceutical compositions comprising aripiprazole - Google Patents

Pharmaceutical compositions comprising aripiprazole Download PDF

Info

Publication number
WO2014104989A8
WO2014104989A8 PCT/TR2012/000232 TR2012000232W WO2014104989A8 WO 2014104989 A8 WO2014104989 A8 WO 2014104989A8 TR 2012000232 W TR2012000232 W TR 2012000232W WO 2014104989 A8 WO2014104989 A8 WO 2014104989A8
Authority
WO
WIPO (PCT)
Prior art keywords
aripiprazole
pharmaceutical compositions
disorder
schizophrenia
shall
Prior art date
Application number
PCT/TR2012/000232
Other languages
French (fr)
Other versions
WO2014104989A1 (en
Inventor
Mahmut Bilgic
Original Assignee
Mahmut Bilgic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mahmut Bilgic filed Critical Mahmut Bilgic
Publication of WO2014104989A1 publication Critical patent/WO2014104989A1/en
Publication of WO2014104989A8 publication Critical patent/WO2014104989A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to pharmaceutical formulations comprising aripiprazole that shall be used in treatment of irritability associated with schizophrenia, bipolar disorder, major depression, autistic disorder.
PCT/TR2012/000232 2011-12-27 2012-12-27 Pharmaceutical compositions comprising aripiprazole WO2014104989A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2011/12993 2011-12-27
TR201112993 2011-12-27

Publications (2)

Publication Number Publication Date
WO2014104989A1 WO2014104989A1 (en) 2014-07-03
WO2014104989A8 true WO2014104989A8 (en) 2014-08-14

Family

ID=47684008

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2012/000232 WO2014104989A1 (en) 2011-12-27 2012-12-27 Pharmaceutical compositions comprising aripiprazole

Country Status (1)

Country Link
WO (1) WO2014104989A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091349A1 (en) * 2012-04-30 2015-01-28 Otsuka Pharma Co Ltd ORAL FORMULATION
TWI730087B (en) * 2016-04-25 2021-06-11 日商大塚製藥股份有限公司 Composition and apparatus for ingestible administration of pharmaceutical product with ingestible event marker
IT201900020350A1 (en) * 2019-11-05 2021-05-05 Alpex Pharma Sa Vardenafil orodispersible formulation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
EP1858514B1 (en) * 2005-03-17 2014-11-26 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
PL1808164T3 (en) * 2006-01-05 2009-06-30 Teva Pharma Wet granulation method for preparing pharmaceutical compositions of aripiprazole
TR200604349A2 (en) * 2006-08-15 2008-03-21 NOBEL İLAÇ SANAYii VE TiCARET A.Ş. Pharmaceutical compositions containing aripiprazole
EP2081904B1 (en) * 2006-09-22 2011-03-02 Krka Tovarna Zdravil, D.D., Novo Mesto Aripiprazole hemifumarate and process for its preparation
WO2010079506A2 (en) * 2008-06-23 2010-07-15 Torrent Pharmaceuticals Ltd. Pharmaceutical composition of aripiprazole
WO2011032882A1 (en) * 2009-09-15 2011-03-24 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole
TR201000948A1 (en) * 2010-02-09 2011-08-22 Sanovel İlaç San.Ve Ti̇c.A.Ş. Aripiprazole formulations.
DE102010019416A1 (en) * 2010-05-04 2011-11-10 Stada Arzneimittel Ag Orodispersible tablet comprising a triptan or an atypical neuroleptic

Also Published As

Publication number Publication date
WO2014104989A1 (en) 2014-07-03

Similar Documents

Publication Publication Date Title
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
IN2014DN09434A (en)
WO2013151736A3 (en) In vivo production of proteins
PH12014501702A1 (en) Imidazopyrrolidinone compounds
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
GB201209613D0 (en) New compounds
IN2015DN03327A (en)
MX366899B (en) New compounds.
PH12014501991B1 (en) Phenicol antibacterials
IN2015KN00005A (en)
WO2014057362A3 (en) Omega -3 compositions
GB2502032A (en) Vitamin D composition
IN2014DN06104A (en)
MX357284B (en) Quinone compounds for treating ape1 mediated diseases.
TR201910866T4 (en) Combined preparations for cancer treatment.
EP2931310A4 (en) Compositions, methods of administration and uses for trivalent dengue virus formulations
MX2015000179A (en) Itraconazole compositions and dosage forms, and methods of using the same.
EP2846839A4 (en) Formulations for the delivery of active ingredients
WO2014104989A8 (en) Pharmaceutical compositions comprising aripiprazole
MX355719B (en) Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum.
UA117567C2 (en) Galactagogue compositions based on phosphatidylserine
MX2014006574A (en) Acamprosate formulations, methods of using the same, and combinations comprising the same.
MX2014006201A (en) Imatinib solid dosage forms reconstituted just before use.
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12823177

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct app. not ent. europ. phase

Ref document number: 12823177

Country of ref document: EP

Kind code of ref document: A1